Did you know that less than five percent of eligible patients participate in cancer clinical trials? Out-of-pocket costs and travel burdens can present significant recruitment challenges for some of the most desperately sought-after research treatments.
Watch as a panel of experts takes an eye-opening look at the barriers affecting the most at-risk patients, and the solutions that can maximize diverse clinical trial enrollment.
Learn what sites, CROs, and patient advocacy groups are doing to make clinical trials accessible to more patients: